Protein cereblon — Drug Target

All drugs that target Protein cereblon — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Thalidomide Analog [EPC] · Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor

Marketed (2)

• Pomalyst · Bristol-Myers Squibb · Thalidomide Analog [EPC] · Oncology
  Pomalyst works by binding to the cereblon protein, which disrupts the function of certain genes involved in cancer cell growth.
• Viekira Pak (Copackaged) · AbbVie · Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor · Oncology